Frisch A, Marino L, Alsaadi D, et al. Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy. J Med Cases. 2026;17(1):28-31. doi:10.14740/jmc5211